INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Holes at Indiana Dunes caused by decayed trees
Researchers say mysterious holes that forced the closure of a massive dune at an Indiana national park after a 6-year-old boy fell into one…
Ex-IU student gets probation in rape plea deal
A former IU student who had been charged in two rape cases will only have to serve probation after a plea deal with prosecutors.
Justin Bieber may be hobbling in Indy tonight
A sold out Bankers Life Fieldhouse probably won't care, but Justin Bieber may not have as many smooth moves on stage Saturday night.
Convoy of Hope brings help to those in need
The Convoy of Hope believes it brings just that – hope – to families who could use some.
WATCH: Dalai Lama speaks at State Fairgrounds
The Dalai Lama will speak to followers Saturday at the Indiana State Fairgrounds.